IRF4 and Miyoshi myopathy: Collectively, our data demonstrate that the underlying molecular mechanism for the 7p15.3 MM risk locus is mediated through rs4487645, which resides within a transcriptional enhancer and disrupts an IRF4 transcription factor-binding site.